Acorda Therapeutics Inc

NASDAQ:ACOR   3:55:58 PM EDT
0.56
-0.02 (-4.18%)
Products

Acorda Therapeutics And Biopas Laboratories Agree To Commercialize Inbrija In Latin America

Published: 05/11/2022 20:41 GMT
Acorda Therapeutics Inc (ACOR) - Acorda Therapeutics and Biopas Laboratories Announce Agreement to Commercialize Inbrija® in Latin America.
Acorda Therapeutics - in Deal, Will Receive a Double-digit, Tiered Percentage of Selling Price of Inbrija in Latin America for Supply of Product.
Acorda Therapeutics Inc - Acorda Will Also Receive Sales-based Milestones.
Acorda Therapeutics - Biopas Will Have Exclusive Distribution Rights to Inbrija in Nine Countries Within Latin America, Including Brazil and Mexico.